Guidant To Retrain Staff In Response To FDA Inspection
This article was originally published in The Gray Sheet
Executive Summary
Guidant will retrain internal quality systems auditors at all of its cardiac rhythm management device manufacturing sites, including in Puerto Rico and Ireland, the company says in its response to a Form 483 issued by FDA last month